Proinsulin misfolding is an early event in the progression to type 2 diabetes.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
11 06 2019
Historique:
received: 19 12 2018
accepted: 09 04 2019
entrez: 12 6 2019
pubmed: 12 6 2019
medline: 3 3 2020
Statut: epublish

Résumé

Biosynthesis of insulin - critical to metabolic homeostasis - begins with folding of the proinsulin precursor, including formation of three evolutionarily conserved intramolecular disulfide bonds. Remarkably, normal pancreatic islets contain a subset of proinsulin molecules bearing at least one free cysteine thiol. In human (or rodent) islets with a perturbed endoplasmic reticulum folding environment, non-native proinsulin enters intermolecular disulfide-linked complexes. In genetically obese mice with otherwise wild-type islets, disulfide-linked complexes of proinsulin are more abundant, and leptin receptor-deficient mice, the further increase of such complexes tracks with the onset of islet insulin deficiency and diabetes. Proinsulin-Cys(B19) and Cys(A20) are necessary and sufficient for the formation of proinsulin disulfide-linked complexes; indeed, proinsulin Cys(B19)-Cys(B19) covalent homodimers resist reductive dissociation, highlighting a structural basis for aberrant proinsulin complex formation. We conclude that increased proinsulin misfolding via disulfide-linked complexes is an early event associated with prediabetes that worsens with ß-cell dysfunction in type two diabetes.

Identifiants

pubmed: 31184302
doi: 10.7554/eLife.44532
pii: 44532
pmc: PMC6559786
doi:
pii:

Substances chimiques

Disulfides 0
Endoplasmic Reticulum Chaperone BiP 0
HSPA5 protein, human 0
Hspa5 protein, mouse 0
Receptors, Leptin 0
Proinsulin 9035-68-1
Cysteine K848JZ4886

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK111174
Pays : United States
Organisme : NIDDK NIH HHS
ID : R24 DK110973
Pays : United States
Organisme : NIDDK NIH HHS
ID : U24 DK098085
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK048280
Pays : United States
Organisme : NIDDK NIH HHS
ID : R24DK110973
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01DK111174
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK113171
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK020572
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK48280
Pays : United States

Informations de copyright

© 2019, Arunagiri et al.

Déclaration de conflit d'intérêts

AA, LH, AP, FP, SK, LZ, AP, JP, BT, PI, RK, ML, PA No competing interests declared

Références

Diabetes. 2017 Mar;66(3):741-753
pubmed: 28028074
Cell. 2017 Dec 14;171(7):1625-1637.e13
pubmed: 29198525
Diabetes. 2016 Apr;65(4):1050-60
pubmed: 26822090
J Biol Chem. 2018 Apr 6;293(14):5134-5149
pubmed: 29444822
Cold Spring Harb Perspect Med. 2012 Sep 01;2(9):a007666
pubmed: 22951443
J Biol Chem. 2016 Jul 8;291(28):14620-7
pubmed: 27226621
Elife. 2019 Jun 11;8:
pubmed: 31184304
Ann N Y Acad Sci. 2018 Apr;1418(1):5-19
pubmed: 29377149
Endocrinology. 2002 Apr;143(4):1530-7
pubmed: 11897712
Adv Exp Med Biol. 2012;771:288-309
pubmed: 23393686
Cell Metab. 2016 Jan 12;23(1):179-93
pubmed: 26626461
J Biol Chem. 2013 Nov 22;288(47):33824-36
pubmed: 24114838
Cell. 1985 Sep;42(2):671-81
pubmed: 3896518
Cell Metab. 2009 Jul;10(1):13-26
pubmed: 19583950
Mol Metab. 2017 Jul 12;6(9):1024-1039
pubmed: 28951826
Diabetologia. 2007 Apr;50(4):752-63
pubmed: 17268797
Sci Signal. 2015 Jun 23;8(382):ra62
pubmed: 26106220
Rev Endocr Metab Disord. 2010 Sep;11(3):205-15
pubmed: 20938745
Diabetologia. 1984 Aug;27(2):225-34
pubmed: 6386585
PLoS One. 2011 Apr 29;6(4):e19446
pubmed: 21559376
J Clin Endocrinol Metab. 2014 Jun;99(6):1983-92
pubmed: 24712577
Anal Biochem. 1969 Oct 1;31(1):146-8
pubmed: 5380692
Cell. 1998 Mar 6;92(5):593-6
pubmed: 9506512
Diabetes. 2016 Feb;65(2):438-50
pubmed: 26307586
Diabetologia. 2009 Jun;52(6):1003-12
pubmed: 19326096
Nat Med. 2005 Jul;11(7):757-64
pubmed: 15980866
Front Endocrinol (Lausanne). 2018 May 02;9:210
pubmed: 29770126
Cell Rep. 2018 Jul 3;24(1):181-196
pubmed: 29972779
Diabetologia. 2007 Dec;50(12):2486-94
pubmed: 17906960
Annu Rev Biochem. 2012;81:767-93
pubmed: 22443930
Diabetologia. 2016 Jun;59(6):1222-30
pubmed: 27048248
Diabetes. 2010 Aug;59(8):1937-47
pubmed: 20530744
J Cell Biol. 2018 Apr 2;217(4):1287-1301
pubmed: 29507125
Diabetes. 2001 Feb;50 Suppl 1:S160-3
pubmed: 11272181
J Biol Chem. 2013 Jan 18;288(3):1896-906
pubmed: 23223446
Diabetes. 1997 May;46(5):887-94
pubmed: 9133560
Mol Metab. 2017 Jun 13;6(8):931-940
pubmed: 28752056
J Cell Biol. 1996 May;133(3):517-27
pubmed: 8636228
Diabetologia. 1970 Jun;6(3):216-42
pubmed: 4914662
J Diabetes Res. 2014;2014:795171
pubmed: 24812634
Metabolism. 2015 Feb;64(2):226-35
pubmed: 25195070
Endocr Rev. 2008 Feb;29(1):42-61
pubmed: 18048764
Diabetes. 2016 Jun;65(6):1472-80
pubmed: 27222391
Nature. 2006 Oct 5;443(7111):548-52
pubmed: 17024087
Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15841-6
pubmed: 17898179
Diabetes Obes Metab. 2018 Sep;20 Suppl 2:95-103
pubmed: 30230182
Diabetes Obes Metab. 2018 Sep;20 Suppl 2:28-50
pubmed: 30230185
J Clin Invest. 1999 Jan;103(1):27-37
pubmed: 9884331
Trends Endocrinol Metab. 2010 Nov;21(11):652-9
pubmed: 20724178
Diabetes. 2017 Aug;66(8):2092-2101
pubmed: 28506962
PLoS One. 2010 Oct 11;5(10):e13333
pubmed: 20948967
J Endocrinol. 2018 Feb;236(2):R109-R143
pubmed: 29203573
J Biol Chem. 2012 Dec 28;287(53):44338-44
pubmed: 23148209
Diabetes Obes Metab. 2010 Oct;12 Suppl 2:48-57
pubmed: 21029300
Med Sci (Paris). 2014 May;30(5):496-9
pubmed: 24939531
Diabetes Obes Metab. 2016 Sep;18 Suppl 1:117-22
pubmed: 27615140
Endocr Rev. 2008 May;29(3):317-33
pubmed: 18436705
J Endocrinol. 2016 Jun;229(3):343-56
pubmed: 27068697
Diabetes. 2019 Apr;68(4):747-760
pubmed: 30670477
J Mol Endocrinol. 2012 May 29;49(1):R9-17
pubmed: 22448029
Mol Aspects Med. 2015 Apr;42:3-18
pubmed: 25542748
PLoS Biol. 2015 Oct 15;13(10):e1002277
pubmed: 26469762
J Biol Chem. 2005 Apr 8;280(14):13209-12
pubmed: 15705595
J Clin Invest. 2010 Aug;120(8):2931-41
pubmed: 20592471
J Clin Endocrinol Metab. 2016 Mar;101(3):1044-54
pubmed: 26713822
Diabetes. 2003 Feb;52(2):409-16
pubmed: 12540615
Biochem Pharmacol. 2002 Jun 1;63(11):1921-35
pubmed: 12093468
Proc Natl Acad Sci U S A. 1997 May 13;94(10):5137-40
pubmed: 9144203
Trends Endocrinol Metab. 2011 Jul;22(7):266-74
pubmed: 21458293

Auteurs

Anoop Arunagiri (A)

Division of Metabolism, Endocrinology & Diabetes, University of Michigan Medical School, Ann Arbor, United States.

Leena Haataja (L)

Division of Metabolism, Endocrinology & Diabetes, University of Michigan Medical School, Ann Arbor, United States.

Anita Pottekat (A)

Degenerative Diseases Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, United States.

Fawnnie Pamenan (F)

Division of Metabolism, Endocrinology & Diabetes, University of Michigan Medical School, Ann Arbor, United States.

Soohyun Kim (S)

Department of Biomedical Science and Technology, Konkuk University, Gwangjin-gu, Republic of Korea.

Lori M Zeltser (LM)

Department of Pathology and Cell Biology, Naomi Berrie Diabetes Center, Columbia University, New York, United States.

Adrienne W Paton (AW)

Research Centre for Infectious Diseases, Department of Molecular and Biomedical Science, University of Adelaide, Adelaide, Australia.

James C Paton (JC)

Research Centre for Infectious Diseases, Department of Molecular and Biomedical Science, University of Adelaide, Adelaide, Australia.

Billy Tsai (B)

Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, United States.

Pamela Itkin-Ansari (P)

Development, Aging and Regeneration Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, United States.

Randal J Kaufman (RJ)

Degenerative Diseases Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, United States.

Ming Liu (M)

Division of Metabolism, Endocrinology & Diabetes, University of Michigan Medical School, Ann Arbor, United States.
Department of Endocrinology and Metabolism, Tianjin Medical University, Tianjin, China.

Peter Arvan (P)

Division of Metabolism, Endocrinology & Diabetes, University of Michigan Medical School, Ann Arbor, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH